Impact of anti-CD20 monoclonal antibodies on serologic response to

Por um escritor misterioso

Last updated 23 março 2025

Impact of anti-CD20 monoclonal antibodies on serologic response to

Frontiers Analysis of vaccine responses after anti-CD20 maintenance in B-cell lymphoma in the Balearic Islands. A single reference center experience

Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20+ B Cell Malignancies - Biology of Blood and Marrow Transplantation

Anti-CD20 monoclonal antibodies and associated viral hepatitis in hematological diseases

Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis, Arthritis Research & Therapy

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

The future of anti-CD20 monoclonal antibodies: are we making progress? - ScienceDirect

JCI Insight - Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune-modifying therapies

Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells

Full article: Anti-CD20 treatment for B-cell malignancies: current status and future directions

Recomendado para você